CT-based radiomics as a non-invasive virtual biopsy for high PD-L1 expression prediction in non-small cell lung cancer
This diagnostic/model validation study was triaged for T6 - Novel Therapeutics (immunotherapy/CAR-T) based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with moderate evidence maturity.
This diagnostic/model validation study was triaged for T6 - Novel Therapeutics (immunotherapy/CAR-T) based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with moderate evidence maturity.
What the study was
- Study design
- Diagnostic/model validation study
- Sample size
- 55
- Maturity
- Validated
- Journal
- Cancer imaging : the official publication of the International Cancer Imaging Society
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.